HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Response to oral supplementation in copper deficiency myeloneuropathy.

Abstract
Neurological manifestations due to copper deficiency include ataxic myeloneuropathy that resembles subacute combined degeneration due to B12 deficiency. We report our experience in the treatment of 10 patients with copper deficiency myeloneuropathy and conclude that copper supplementation leads to stabilization rather than improvement in the neurological deficits.
AuthorsPraful Kelkar, Shereen Chang, Suraj A Muley
JournalJournal of clinical neuromuscular disease (J Clin Neuromuscul Dis) Vol. 10 Issue 1 Pg. 1-3 (Sep 2008) ISSN: 1537-1611 [Electronic] United States
PMID18772693 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Copper
Topics
  • Administration, Oral
  • Adult
  • Aged
  • Copper (administration & dosage, blood, deficiency)
  • Drug Administration Schedule
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Spinal Cord Diseases (drug therapy, etiology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: